Affordable Access

deepdyve-link
Publisher Website

Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes

Authors
  • Cusatis, Rachel1
  • Tecca, Heather R2
  • D’Souza, Anita1
  • Shaw, Bronwen E1
  • Flynn, Kathryn E.1
  • 1 Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
  • 2 Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA
Type
Published Article
Journal
Cancer
Publisher
Wiley (John Wiley & Sons)
Publication Date
Mar 10, 2020
Volume
126
Issue
11
Pages
2679–2686
Identifiers
DOI: 10.1002/cncr.32808
PMID: 32154926
PMCID: PMC7220834
Source
PubMed Central
Keywords
License
Unknown

Abstract

Among patients who underwent allogenic HCT and lived to at least 100 days, most did not report regretting their transplant, though 15% did within 1 year. Relapse significantly increased the risk of reporting regret while baseline social well-being significantly decreased the risk of regret.

Report this publication

Statistics

Seen <100 times